Delayed reactions : These develop hours to days after administration and may manifest as skin rashes, eczema-like changes, or persistent urticaria
SW, JW, DG, TM, PT, and SC contributed to data collection and data processing
TRIUMPH-4: retatrutide 12 mg, the Phase 3 leap of December 2025 TRIUMPH-4 is the first successful Phase 3 readout of the retatrutide program
The Synergistic Effect: Why Combination Therapy May Offer Enhanced Results One of the most interesting developments in perimenopause weight management is how hormone replacement therapy and GLP-1 medications may work together
By utilizing IV therapy, Dr
With recent FDA enforcement against misleading direct-to-consumer prescription drug advertising, telehealth and DTC platforms that advertise GLP-1 products will likely need more careful legal / regulatory oversight of their ad claims, especially around benefit claims and safety disclosures